Literature DB >> 6183549

Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice.

K Ramabadran.   

Abstract

Subcutaneous administrations of naloxone and naltrexone have already been shown to enhance nociceptive reactions in mice. The present study was undertaken to examine the effects of N-methyl-naloxone and N-methylnaltrexone on nociception using the hot plate test (dose range: 0.3 to 30 mg kg-1s.c.). The latter compounds were selected to differentiate the central and peripheral components of hyperalgesia. Unlike naloxone, N-methyl-naloxone did not produce hyperalgesia. Similarly low doses of N-methylnaltrexone did not enhance the jumping response. However, a high dose of N-methylnaltrexone (30 mg kg-1 s.c.) significantly reduced the jumping latencies 2 h after its administration. This phenomenon indicated that it might be converted to an active metabolite. Further, N-methylnaloxone and N-methylnaltrexone were very weak in precipitating the signs of abstinence in mice rendered acutely dependent on morphine. Two factors, poorer penetration into the CNS and steric hindrance, might render the N-methylated antagonists weak. Hence, both these factors should be considered when interpreting the effects after quaternary derivatives of opioid antagonists.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183549     DOI: 10.1016/0024-3205(82)90355-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

2.  The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.

Authors:  Jessica P Anand; Brett T Boyer; Henry I Mosberg; Emily M Jutkiewicz
Journal:  Psychopharmacology (Berl)       Date:  2016-04-27       Impact factor: 4.530

3.  Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.

Authors:  D Matthew Walentiny; Essie Komla; Léa T Moisa; Mohammed A Mustafa; Justin L Poklis; Hamid I Akbarali; Patrick M Beardsley
Journal:  Neuropharmacology       Date:  2020-12-11       Impact factor: 5.250

4.  Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.

Authors:  Alok K Paul; Krystel L Woolley; Mohammed Rahmatullah; Polrat Wilairatana; Jason A Smith; Nuri Gueven; Nikolas Dietis
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.